Literature DB >> 19659787

Drug-induced liver disease: an 8-year study of patients from one gastroenterological department.

Yi Ping Wang1, Bin Shi, Yue Xiang Chen, Jing Xu, Cai Feng Jiang, Wei Fen Xie.   

Abstract

OBJECTIVE: To analyze drug-induced liver disease over an 8-year period from January 2000 to December 2007 in one gastroenterological department.
METHODS: International consensus of standard definitions and criteria for assessing causality of adverse drug reactions were applied to all patients with abnormal hepatic test results.
RESULTS: Drugs were implicated in hepatic injury in 30 patients (15 men and 15 women) in whom there was a causal or highly probable relationship between drug use and liver disease. The drugs responsible for liver damage were Chinese medicinal herbs (n = 12), cyclosporin (n = 2), fosfomycin, gentamicin, flutamide, acipimox and nimesulide (n = 1 each). Of the 30 patients, 19 (63.3%) were classified as having hepatocellular or mixed hepatitis, eight (26.7%) as having cholestatic injury and the remaining three as having a severe hepatic drug reaction (prothrombin < 50%), including death.
CONCLUSION: A thorough history of medication should be taken in all patients presenting with abnormal hepatic test results. Chinese medicinal herbs were the most frequent hepatotoxic factor in our patients, although the liver injury was not severe in most cases and was relieved after the prompt withdrawal of the suspected drug.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19659787     DOI: 10.1111/j.1751-2980.2009.00385.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  4 in total

1.  Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey.

Authors:  Shaoli You; Yihui Rong; Bing Zhu; Aimin Zhang; Hong Zang; Hongling Liu; Dongze Li; Zhihong Wan; Shaojie Xin
Journal:  Hepatol Int       Date:  2013-02-07       Impact factor: 6.047

2.  An overview of the evidence and mechanisms of herb-drug interactions.

Authors:  Pius S Fasinu; Patrick J Bouic; Bernd Rosenkranz
Journal:  Front Pharmacol       Date:  2012-04-30       Impact factor: 5.810

Review 3.  An Update on Treatment of Drug-Induced Liver Injury.

Authors:  Christin Giordano; John Rivas; Xaralambos Zervos
Journal:  J Clin Transl Hepatol       Date:  2014-06-15

4.  Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database.

Authors:  Dmitri Iarikov; Ronald Wassel; John Farley; Sumathi Nambiar
Journal:  Infect Dis Ther       Date:  2015-10-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.